RORgammat inverse agonists demonstrating a margin between inhibition of IL-17A and thymocyte apoptosis. Collins M, Pehrson R, Grindebacke H, Leffler A, et al. PLoS One 2025;20:e0317090.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Collins M, Pehrson R, Grindebacke H, Leffler A, et al. RORgammat inverse agonists demonstrating a margin between inhibition of IL-17A and thymocyte apoptosis. PLoS One 2025;20:e0317090.
PMID: 39820614